Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 18/20 | 0.54 |
| ▸ | PPARG | P37231 | 14/20 | 0.54 |
| ▸ | PPARD | Q03181 | 9/20 | 0.54 |
| ▸ | RXRA | P19793 | 1/20 | 0.48 |
| ▸ | RXRB | P28702 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6715972 | 0.86 | OPRK1 (0.48) | PPARAPPARGPPARDRXRARXRB | |
| SCHEMBL6713537 | 0.76 | OPRK1 (0.49) | PPARAPPARGPPARDRXRARXRB | |
| SCHEMBL1290714 | 0.76 | TAAR1 (0.54) | RXRARXRB | |
| SCHEMBL6713621 | 0.75 | PPARA (0.57) | PPARAPPARGPPARD | |
| SCHEMBL30125294 | 0.75 | BLM (0.59) | PPARAPPARGPPARDKDM4EPOLB | |
| SCHEMBL6713362 | 0.72 | RXRA (0.55) | PPARAPPARGRXRARXRBKDM4E | |
| SCHEMBL6715217 | 0.72 | OPRK1 (0.45) | PPARAPPARGPPARDRXRARXRB | |
| SCHEMBL5099266 | 0.71 | PPARG (0.72) | PPARAPPARGPPARDKDM4E | |
| SCHEMBL13809681 | 0.71 | PPARA (0.50) | PPARAPPARGPPARD | |
| SCHEMBL7650076 | 0.71 | LTA4H (0.46) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040006141-A1 | Amidocarboxylic acid compounds | SANKYO COMPANY, LTD (JP) | 2004-01-08 | — | — | US | disclosed |
| US-6528525-B1 | Amidocarboxylic acid derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-03-04 | — | — | US | disclosed |
| EP-1026149-A1 | AMIDOCARBOXYLIC ACID DERIVATIVES | Sankyo Company Limited (JP) | 2000-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040006141-A1 | Amidocarboxylic acid compounds | NR1H2, AGK, APOL1 | PPARA 71/4885PPARG 23/4885PPARD 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.